Bayer just bought Bluerock Tx showing a growing confidence in iPSC Therapy development
Bayer buys BlueRock in $600 million bet on stem cell therapies
By Ludwig Burger FRANKFURT (Reuters) – German drugmaker Bayer is paying up to $600 million (493.67 million pounds) for full control of cell therap...
Report from the ISCBI/GAiT/HSCI meeting held in Boston was just published in the latest issue of
(link: https://t.co/Hlp8nW2LLB) https://t.co/UP6ig54tPj
ISCT NA 2019 Plenary Spotlight: iPSC and Pluripotent Stem Cells - True Replacement Cell Therapies. Read more about this session at and register now https://t.co/IC72dsiGXg!
GAiT will speak at the 4th Annual Cell and Gene Therapy Symposium 5/6 September2019 at the Centre for Stem Cell Research, Vellore, India
GAiT will speak at Phaciliate Leaders World 17th - 18th SEPTEMBER 2019 in London
The agenda for this years conference has been designed to address the 3 core challenges presented by the European advanced therapies market: investmen...
The Promise and Price of Cellular Therapies by Siddhartha Mukherjee #celltherapy #genetherapy
The Promise and Price of Cellular Therapies
New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them?
Update on the Quality Round will be issued later this week. We are currently clearing a backlog of GAiT internal administrative issues. Thanks for your patience.
The number of autologous products under clinical development is likely to cause a strain on #QC provision. Listen to this webinar on demand as Head of Quality Control Doli Patel considers some the challenges #webinar - https://t.co/orXn1sETRu
Pluripotent Stem Cells Manufacturing Expert Panels 2019: audio recordings and slides from yesterday's event can be accessed by GAiT members at https://t.co/CbkfFrpKgj . Thanks to all Chairs/Participants.
We will be livestreaming the PSC Manufacturing Expert Panels 2019 tomorrow. See the agenda at https://t.co/CbkfFrpKgj and see start time in different time zones at https://t.co/uJfOfggacu
Logistical Challenges facing PSC/iPSC manufacturing and how to surmount them: Dr Simon Ellison of World Courier @ PSC Manufacturing Expert Panels 2019
IPSCs for off-the-shelf therapies? #stemcells #cancer
Eric Topol on Twitter
“"Universal" induced pluripotent stem cell therapy? A clinical trial in #cancer is underway https://t.co/GKvY80TZ94 @CellPressNews by @Catalytic...
GAiT and collaborators (ISCT, CIRM, HESI CT-TRACS & ISCBI) will host a series of Expert Panels on topics pertinant to the manufacture of human Pluripotent Stem Cells 30 JUNE 2019 in L.A. The event will be live-streamed & also edited recordings will be posted on our websites
GAiT will have multiple speakers at this event in September 2019
Phacilitate on Twitter
“Early Bird tickets are now available for #PLE2019! Register your place today: https://t.co/f3l7j5yv3I #europe #advancedtherapies #celltherapy...
It was GAiT's honour to describe rationale for, & design of, the iPSC Quality Round 2019 at #ISCT2019, listing all Organizers and Participants. We are grateful to @ISCTglobal (International Society for Cell and Gene Therapy) for allowing us describe this important initiative.